Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concordance of two polymerase chain reaction-based blood group genotyping platforms for patients with sickle cell disease.

Immunohematology - 1 Dec 2020

Sheppard Chelsea A, Bolen Nicole L, Meny Geralyn, Kalvelage Monica, Ochoa-Garay Gorka

Abstract excerpt

CONCLUSIONS: In recent years, polymerase chain reaction-based genotyping platforms, which provide a predicted phenotype, have increased in both patient and high-throughput donor testing, especially in situations where serologic methods or reagents are limited. This study looks at the concordance rate between two platforms commercially available in the United States when used for testing samples from patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to Blood Group Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Genotyping Techniques

Share to Polymerase Chain Reaction

Share to Rh-Hr Blood-Group System

Source

Identifiers

PMID: 33544616

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concordance of two polymerase chain reaction-based blood group genotyping platforms for patients with sickle cell disease.PMID 33544616Read ↗

Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.Semantic proximity Read ↗

Blood group genotype matching for transfusionSemantic proximity Read ↗

RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients.Semantic proximity Read ↗

Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.Semantic proximity Read ↗

Changing practice: red blood cell typing by molecular methods for patients with sickle cell diseaseSemantic proximity Read ↗

Next-Generation Sequencing Technologies in Blood Group TypingSemantic proximity Read ↗

Emerging strategies of blood group genotyping for patients with hemoglobinopathies.Semantic proximity Read ↗

RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.Semantic proximity Read ↗

Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell diseaseSemantic proximity Read ↗

The experience of extended blood group genotyping by next-generation sequencing (NGS): investigation of patients with sickle-cell disease.Semantic proximity Read ↗

Machine learning to optimize automated RH genotyping using whole-exome sequencing data.Semantic proximity Read ↗

High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.